Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07281885

Aromatherapy in Reducing PONV for Total Joint Replacement Patients

Led by Hong Kong Buddhist Hospital · Updated on 2026-01-07

159

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

Sponsors

H

Hong Kong Buddhist Hospital

Lead Sponsor

Q

Queen Elizabeth Hospital, Hong Kong

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study investigates the effectiveness of aromatherapy in reducing postoperative nausea and vomiting (PONV) among patients undergoing total joint replacement surgery, as these complications can lead to patient discomfort and prolonged recovery. It is designed as a randomized controlled trial involving 159 participants, who will be divided into three groups: an intervention group receiving aromatherapy patches (lavender-sandalwood or orange-ginger) plus standard care, a placebo group with a placebo patch plus standard care, and a control group receiving standard care alone. PONV will be measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) at baseline, 30 minutes after the intervention, and every 12 hours post-surgery. Additionally, patient satisfaction will be assessed through a 5-point Likert scale survey. The primary outcome of the study is the evaluation of RINVR scores, while the secondary outcome focuses on patient satisfaction levels. Data will be statistically analyzed using two-way ANOVA for repeated measures, with a significance level defined as p \< 0.05. The study aims to determine the viability of aromatherapy as a complementary treatment for PONV, potentially improving postoperative care, enhancing patient satisfaction, and offering a cost-effective alternative to conventional anti emetic treatments if proven effective.

CONDITIONS

Official Title

Aromatherapy in Reducing PONV for Total Joint Replacement Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 or above
  • Patients scheduled for total joint replacement surgery at the HKBH
Not Eligible

You will not qualify if you...

  • Cognitive impairments
  • Allergy to lavender, orange, ginger, or sandalwood
  • Allergy to micro-pore tape
  • Allergy to opioid medication
  • Undergoing other therapeutic treatment for PONV control, except prescribed medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hong Kong Buddhist Hospital

Wong Tai Sin, Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

C

Choi Wan CHAN, APN (NURSING)

CONTACT

V

Victor CHEUNG, EOII(MDSSC)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here